What Happened?
Shares of healthcare services company Agilon Health (NYSE: AGL) fell 10.8% in the afternoon session after Citi downgraded the stock's rating from Neutral to Sell, citing valuation concerns. The downgrade followed a massive 650% rally in 2026, which left the stock trading at a 38% premium compared to its peers. Citi noted this valuation was "too rich," especially since the company faced risks as Medicare Advantage plans sought to retain margins heading into 2027. Despite raising the price target from $80 to $105, the firm placed a "downside 30-day catalyst watch" on the stock, indicating a significant second-quarter earnings beat was unlikely. Adding to the negative sentiment, a law firm announced an investigation into the company regarding potential false statements about its medical costs.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy agilon health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
agilon health’s shares are extremely volatile and have had 98 moves greater than 5% over the last year. But moves this big are rare even for agilon health and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 12 months ago when the stock dropped 51.6% on the news that the company reported dismal second-quarter financial results, announced the departure of its CEO, and withdrew its full-year guidance. The company's revenue missed analyst estimates and its net loss more than doubled expectations. The poor performance stemmed from a significant reversal in its medical margin, which swung from a $106 million profit in the same quarter last year to a $53 million loss, driven by reductions in expected revenue. Concurrently, Agilon announced that President and CEO Steven Sell stepped down. Citing the leadership change and market uncertainty, the company suspended its 2025 financial forecast, which deepened investor concerns.
agilon health is up 525% since the beginning of the year, but at $105.27 per share, it is still trading 18.9% below its 52-week high of $129.84 from July 2026. Despite the year-to-date gain, investors who bought $1,000 worth of agilon health’s shares 5 years ago would now be looking at only $114.17.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
